Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0048638,GO:0048638,regulation of developmental growth,6/20,329/18800,8.64912313770692e-07,0.0008242614350234,0.0003687257758706,AGRN/CSF1/FGFR2/GDF15/NPPC/TGFBR2,6
GO:0003416,GO:0003416,endochondral bone growth,3/20,28/18800,3.31611020462902e-06,0.0014424555011453,0.0006452692085534,FGFR2/NPPC/TGFBR2,3
GO:0098868,GO:0098868,bone growth,3/20,31/18800,4.54078331945026e-06,0.0014424555011453,0.0006452692085534,FGFR2/NPPC/TGFBR2,3
GO:0060443,GO:0060443,mammary gland morphogenesis,3/20,44/18800,1.32614120838591e-05,0.0026811843912501,0.0011994031904305,CSF1/FGFR2/TGFBR2,3
GO:0048754,GO:0048754,branching morphogenesis of an epithelial tube,4/20,153/18800,1.84616754492125e-05,0.0026811843912501,0.0011994031904305,CSF1/CTSZ/FGFR2/TGFBR2,4
GO:0060425,GO:0060425,lung morphogenesis,3/20,50/18800,1.95460410947993e-05,0.0026811843912501,0.0011994031904305,CTSZ/FGFR2/TGFBR2,3
GO:0060462,GO:0060462,lung lobe development,2/20,7/18800,2.25073191290672e-05,0.0026811843912501,0.0011994031904305,FGFR2/TGFBR2,2
GO:0060463,GO:0060463,lung lobe morphogenesis,2/20,7/18800,2.25073191290672e-05,0.0026811843912501,0.0011994031904305,FGFR2/TGFBR2,2
GO:0003149,GO:0003149,membranous septum morphogenesis,2/20,8/18800,2.99906054673299e-05,0.0028581047010365,0.0012785468646598,FGFR2/TGFBR2,2
GO:0003418,GO:0003418,growth plate cartilage chondrocyte differentiation,2/20,10/18800,4.81376855736618e-05,0.0032768010251214,0.0014658468163408,NPPC/TGFBR2,2
GO:0035860,GO:0035860,glial cell-derived neurotrophic factor receptor signaling pathway,2/20,10/18800,4.81376855736618e-05,0.0032768010251214,0.0014658468163408,GDF15/GFRA1,2
GO:0001763,GO:0001763,morphogenesis of a branching structure,4/20,199/18800,5.16729590224334e-05,0.0032829553298919,0.001468599888006,CSF1/CTSZ/FGFR2/TGFBR2,4
GO:0050920,GO:0050920,regulation of chemotaxis,4/20,225/18800,8.32519901781653e-05,0.0046685239617876,0.0020884212785375,CSF1/NBL1/PGF/SCG2,4
GO:0002664,GO:0002664,regulation of T cell tolerance induction,2/20,13/18800,8.32790213540285e-05,0.0046685239617876,0.0020884212785375,IL2RA/TGFBR2,2
GO:0097529,GO:0097529,myeloid leukocyte migration,4/20,229/18800,8.91299088928615e-05,0.0047189335097165,0.0021109715264098,CSF1/NBL1/PGF/SCG2,4
GO:0030595,GO:0030595,leukocyte chemotaxis,4/20,236/18800,0.0001001364851138,0.0047715035156744,0.0021344882353213,CSF1/NBL1/PGF/SCG2,4
GO:0045927,GO:0045927,positive regulation of growth,4/20,256/18800,0.0001370365462283,0.0056780795024169,0.0025400366692205,AGRN/CSF1/FGFR2/TGFBR2,4
GO:0002053,GO:0002053,positive regulation of mesenchymal cell proliferation,2/20,23/18800,0.0002684046182591,0.0094662825875035,0.0042346544959837,FGFR2/TGFBR2,2
GO:0002688,GO:0002688,regulation of leukocyte chemotaxis,3/20,124/18800,0.0002941288342063,0.0094662825875035,0.0042346544959837,CSF1/NBL1/PGF,3
GO:0032946,GO:0032946,positive regulation of mononuclear cell proliferation,3/20,143/18800,0.0004467844859096,0.0106446403767975,0.0047617820208792,CSF1/IL2RA/TGFBR2,3
GO:1902107,GO:1902107,positive regulation of leukocyte differentiation,3/20,157/18800,0.0005867960637496,0.0123837773488675,0.0055397689581834,CSF1/IL2RA/TGFBR2,3
GO:1903708,GO:1903708,positive regulation of hemopoiesis,3/20,157/18800,0.0005867960637496,0.0123837773488675,0.0055397689581834,CSF1/IL2RA/TGFBR2,3
GO:0048660,GO:0048660,regulation of smooth muscle cell proliferation,3/20,170/18800,0.0007395159933451,0.0146824737845392,0.0065680696777361,FGFR2/NPPC/TGFBR2,3
GO:0048659,GO:0048659,smooth muscle cell proliferation,3/20,173/18800,0.0007780183481562,0.0149092615769716,0.0066695211119163,FGFR2/NPPC/TGFBR2,3
GO:0009410,GO:0009410,response to xenobiotic stimulus,4/20,411/18800,0.0008260965282084,0.0149092615769716,0.0066695211119163,NPPC/PGF/PON3/TGFBR2,4
GO:0010463,GO:0010463,mesenchymal cell proliferation,2/20,41/18800,0.000859997836875,0.0149092615769716,0.0066695211119163,FGFR2/TGFBR2,2
GO:0007369,GO:0007369,gastrulation,3/20,190/18800,0.0010204371715365,0.0149092615769716,0.0066695211119163,FGFR2/IL1RN/TGFBR2,3
GO:0035602,GO:0035602,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell,1/20,1/18800,0.001063829787234,0.0149092615769716,0.0066695211119163,FGFR2,1
GO:0035603,GO:0035603,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,1/20,1/18800,0.001063829787234,0.0149092615769716,0.0066695211119163,FGFR2,1
GO:0035604,GO:0035604,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,1/20,1/18800,0.001063829787234,0.0149092615769716,0.0066695211119163,FGFR2,1
GO:0035607,GO:0035607,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,1/20,1/18800,0.001063829787234,0.0149092615769716,0.0066695211119163,FGFR2,1
GO:0045887,GO:0045887,positive regulation of synaptic assembly at neuromuscular junction,1/20,1/18800,0.001063829787234,0.0149092615769716,0.0066695211119163,AGRN,1
GO:0072027,GO:0072027,connecting tubule development,1/20,1/18800,0.001063829787234,0.0149092615769716,0.0066695211119163,CALB1,1
GO:0072286,GO:0072286,metanephric connecting tubule development,1/20,1/18800,0.001063829787234,0.0149092615769716,0.0066695211119163,CALB1,1
GO:1902228,GO:1902228,positive regulation of macrophage colony-stimulating factor signaling pathway,1/20,1/18800,0.001063829787234,0.0149092615769716,0.0066695211119163,CSF1,1
GO:1905317,GO:1905317,inferior endocardial cushion morphogenesis,1/20,1/18800,0.001063829787234,0.0149092615769716,0.0066695211119163,TGFBR2,1
GO:0048701,GO:0048701,embryonic cranial skeleton morphogenesis,2/20,46/18800,0.0010820305372283,0.0149445666953424,0.0066853145320745,FGFR2/TGFBR2,2
GO:0010862,GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,2/20,49/18800,0.001227088885884,0.0163451509762792,0.0073118530351721,GDF15/TGFBR2,2
GO:0060043,GO:0060043,regulation of cardiac muscle cell proliferation,2/20,49/18800,0.001227088885884,0.0163451509762792,0.0073118530351721,FGFR2/TGFBR2,2
GO:0060541,GO:0060541,respiratory system development,3/20,203/18800,0.001234890734829,0.0163451509762792,0.0073118530351721,CTSZ/FGFR2/TGFBR2,3
GO:0050679,GO:0050679,positive regulation of epithelial cell proliferation,3/20,211/18800,0.0013799951932281,0.0180155536869377,0.0080590923324789,FGFR2/PGF/SCG2,3
GO:0002274,GO:0002274,myeloid leukocyte activation,3/20,232/18800,0.0018108170008889,0.0202710449750984,0.0090680656264592,CSF1/HAVCR1/TGFBR2,3
GO:0060560,GO:0060560,developmental growth involved in morphogenesis,3/20,234/18800,0.001855742559938,0.0202710449750984,0.0090680656264592,CSF1/FGFR2/TGFBR2,3
GO:0097305,GO:0097305,response to alcohol,3/20,235/18800,0.0018784654390671,0.0202710449750984,0.0090680656264592,FGFR2/NPPC/TGFBR2,3
GO:0050918,GO:0050918,positive chemotaxis,2/20,64/18800,0.0020835716112311,0.0202710449750984,0.0090680656264592,PGF/SCG2,2
GO:0010124,GO:0010124,phenylacetate catabolic process,1/20,2/18800,0.0021265843701509,0.0202710449750984,0.0090680656264592,PON3,1
GO:0021847,GO:0021847,ventricular zone neuroblast division,1/20,2/18800,0.0021265843701509,0.0202710449750984,0.0090680656264592,FGFR2,1
GO:0042488,GO:0042488,positive regulation of odontogenesis of dentin-containing tooth,1/20,2/18800,0.0021265843701509,0.0202710449750984,0.0090680656264592,CSF1,1
GO:0046226,GO:0046226,coumarin catabolic process,1/20,2/18800,0.0021265843701509,0.0202710449750984,0.0090680656264592,PON3,1
GO:0046271,GO:0046271,phenylpropanoid catabolic process,1/20,2/18800,0.0021265843701509,0.0202710449750984,0.0090680656264592,PON3,1
GO:0060529,GO:0060529,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,1/20,2/18800,0.0021265843701509,0.0202710449750984,0.0090680656264592,FGFR2,1
GO:0060595,GO:0060595,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,1/20,2/18800,0.0021265843701509,0.0202710449750984,0.0090680656264592,FGFR2,1
GO:1904398,GO:1904398,positive regulation of neuromuscular junction development,1/20,2/18800,0.0021265843701509,0.0202710449750984,0.0090680656264592,AGRN,1
GO:0031100,GO:0031100,animal organ regeneration,2/20,65/18800,0.0021483478934784,0.0202710449750984,0.0090680656264592,PGF/TGFBR2,2
GO:0071560,GO:0071560,cellular response to transforming growth factor beta stimulus,3/20,252/18800,0.0022917823151224,0.0210006590991507,0.0093944517978196,FGFR2/GDF15/TGFBR2,3
GO:0071559,GO:0071559,response to transforming growth factor beta,3/20,258/18800,0.0024501107869327,0.0218220147658592,0.0097618777049461,FGFR2/GDF15/TGFBR2,3
GO:1904888,GO:1904888,cranial skeletal system development,2/20,70/18800,0.0024864254410845,0.0218959322678153,0.0097949440199538,FGFR2/TGFBR2,2
GO:0061448,GO:0061448,connective tissue development,3/20,260/18800,0.002504361613003,0.0218959322678153,0.0097949440199538,CSF1/NPPC/TGFBR2,3
GO:0090092,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,3/20,267/18800,0.0027001169344156,0.0225757440193815,0.0100990515577948,GDF15/NBL1/TGFBR2,3
GO:0002437,GO:0002437,inflammatory response to antigenic stimulus,2/20,75/18800,0.0028479909899905,0.0233724333363885,0.0104554432001296,IL1RN/IL2RA,2
GO:0098742,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,3/20,279/18800,0.0030573181134673,0.0233724333363885,0.0104554432001296,IL1RN/NECTIN4/TGFBR2,3
GO:0021769,GO:0021769,orbitofrontal cortex development,1/20,3/18800,0.0031882647783111,0.0233724333363885,0.0104554432001296,FGFR2,1
GO:0032929,GO:0032929,negative regulation of superoxide anion generation,1/20,3/18800,0.0031882647783111,0.0233724333363885,0.0104554432001296,PON3,1
GO:0046013,GO:0046013,regulation of T cell homeostatic proliferation,1/20,3/18800,0.0031882647783111,0.0233724333363885,0.0104554432001296,IL2RA,1
GO:0060400,GO:0060400,negative regulation of growth hormone receptor signaling pathway,1/20,3/18800,0.0031882647783111,0.0233724333363885,0.0104554432001296,GDF15,1
GO:0060523,GO:0060523,prostate epithelial cord elongation,1/20,3/18800,0.0031882647783111,0.0233724333363885,0.0104554432001296,FGFR2,1
GO:1900194,GO:1900194,negative regulation of oocyte maturation,1/20,3/18800,0.0031882647783111,0.0233724333363885,0.0104554432001296,NPPC,1
GO:1990428,GO:1990428,miRNA transport,1/20,3/18800,0.0031882647783111,0.0233724333363885,0.0104554432001296,TGFBR2,1
GO:0001666,GO:0001666,response to hypoxia,3/20,286/18800,0.0032785432710748,0.0236700889191997,0.0105885966888782,NPPC/PGF/TGFBR2,3
GO:0032943,GO:0032943,mononuclear cell proliferation,3/20,300/18800,0.0037500782122401,0.0266703323601854,0.0119307280122329,CSF1/IL2RA/TGFBR2,3
GO:0009791,GO:0009791,post-embryonic development,2/20,87/18800,0.0038101850782532,0.0266993116145245,0.0119436916152675,FGFR2/NPPC,2
GO:0051781,GO:0051781,positive regulation of cell division,2/20,89/18800,0.003983348758262,0.0269945003629889,0.0120757415883476,FGFR2/PGF,2
GO:0038098,GO:0038098,sequestering of BMP from receptor via BMP binding,1/20,4/18800,0.0042488720403445,0.0269945003629889,0.0120757415883476,NBL1,1
GO:0071866,GO:0071866,negative regulation of apoptotic process in bone marrow cell,1/20,4/18800,0.0042488720403445,0.0269945003629889,0.0120757415883476,FGFR2,1
GO:1990086,GO:1990086,lens fiber cell apoptotic process,1/20,4/18800,0.0042488720403445,0.0269945003629889,0.0120757415883476,TGFBR2,1
GO:0032963,GO:0032963,collagen metabolic process,2/20,101/18800,0.0050977873787308,0.0284208541927156,0.0127138078622078,MMP7/NPPC,2
GO:0042102,GO:0042102,positive regulation of T cell proliferation,2/20,103/18800,0.0052959679986202,0.0284208541927156,0.0127138078622078,IL2RA/TGFBR2,2
GO:0003186,GO:0003186,tricuspid valve morphogenesis,1/20,5/18800,0.0053084071839489,0.0284208541927156,0.0127138078622078,TGFBR2,1
GO:0060664,GO:0060664,epithelial cell proliferation involved in salivary gland morphogenesis,1/20,5/18800,0.0053084071839489,0.0284208541927156,0.0127138078622078,FGFR2,1
GO:1905007,GO:1905007,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,1/20,5/18800,0.0053084071839489,0.0284208541927156,0.0127138078622078,TGFBR2,1
GO:2000563,GO:2000563,"positive regulation of CD4-positive, alpha-beta T cell proliferation",1/20,5/18800,0.0053084071839489,0.0284208541927156,0.0127138078622078,TGFBR2,1
GO:0071692,GO:0071692,protein localization to extracellular region,3/20,359/18800,0.0061846981058043,0.0288934680371775,0.0129252273209884,IL1RN/NBL1/SCG2,3
GO:0002023,GO:0002023,reduction of food intake in response to dietary excess,1/20,6/18800,0.0063668712358943,0.0288934680371775,0.0129252273209884,GDF15,1
GO:0010757,GO:0010757,negative regulation of plasminogen activation,1/20,6/18800,0.0063668712358943,0.0288934680371775,0.0129252273209884,CTSZ,1
GO:0043415,GO:0043415,positive regulation of skeletal muscle tissue regeneration,1/20,6/18800,0.0063668712358943,0.0288934680371775,0.0129252273209884,TGFBR2,1
GO:0045162,GO:0045162,clustering of voltage-gated sodium channels,1/20,6/18800,0.0063668712358943,0.0288934680371775,0.0129252273209884,AGRN,1
GO:0071352,GO:0071352,cellular response to interleukin-2,1/20,6/18800,0.0063668712358943,0.0288934680371775,0.0129252273209884,IL2RA,1
GO:0071839,GO:0071839,apoptotic process in bone marrow cell,1/20,6/18800,0.0063668712358943,0.0288934680371775,0.0129252273209884,FGFR2,1
GO:0071864,GO:0071864,positive regulation of cell proliferation in bone marrow,1/20,6/18800,0.0063668712358943,0.0288934680371775,0.0129252273209884,FGFR2,1
GO:1903969,GO:1903969,regulation of response to macrophage colony-stimulating factor,1/20,6/18800,0.0063668712358943,0.0288934680371775,0.0129252273209884,CSF1,1
GO:0010753,GO:0010753,positive regulation of cGMP-mediated signaling,1/20,7/18800,0.0074242652220225,0.0308966146575873,0.0138213165475483,NPPC,1
GO:0051124,GO:0051124,synaptic assembly at neuromuscular junction,1/20,7/18800,0.0074242652220225,0.0308966146575873,0.0138213165475483,AGRN,1
GO:0061518,GO:0061518,microglial cell proliferation,1/20,7/18800,0.0074242652220225,0.0308966146575873,0.0138213165475483,CSF1,1
GO:0090027,GO:0090027,negative regulation of monocyte chemotaxis,1/20,7/18800,0.0074242652220225,0.0308966146575873,0.0138213165475483,NBL1,1
GO:1903430,GO:1903430,negative regulation of cell maturation,1/20,7/18800,0.0074242652220225,0.0308966146575873,0.0138213165475483,NPPC,1
GO:0048706,GO:0048706,embryonic skeletal system development,2/20,127/18800,0.0079443291244692,0.0326333864466346,0.0145982454419694,FGFR2/TGFBR2,2
GO:0030916,GO:0030916,otic vesicle formation,1/20,8/18800,0.0084805901672442,0.0327206576088411,0.0146372853941356,FGFR2,1
GO:0070669,GO:0070669,response to interleukin-2,1/20,8/18800,0.0084805901672442,0.0327206576088411,0.0146372853941356,IL2RA,1
GO:0071694,GO:0071694,maintenance of protein location in extracellular region,1/20,8/18800,0.0084805901672442,0.0327206576088411,0.0146372853941356,NBL1,1
GO:0045667,GO:0045667,regulation of osteoblast differentiation,2/20,136/18800,0.0090630217370468,0.0347198033458836,0.0155315848622995,FGFR2/NPPC,2
GO:0001503,GO:0001503,ossification,3/20,420/18800,0.0095142207691483,0.0347198033458836,0.0155315848622995,CSF1/FGFR2/NPPC,3
GO:0002002,GO:0002002,regulation of angiotensin levels in blood,1/20,9/18800,0.0095358470955464,0.0347198033458836,0.0155315848622995,CTSZ,1
GO:0002003,GO:0002003,angiotensin maturation,1/20,9/18800,0.0095358470955464,0.0347198033458836,0.0155315848622995,CTSZ,1
GO:0006924,GO:0006924,activation-induced cell death of T cells,1/20,9/18800,0.0095358470955464,0.0347198033458836,0.0155315848622995,IL2RA,1
GO:0002696,GO:0002696,positive regulation of leukocyte activation,3/20,421/18800,0.0095760196183942,0.0347198033458836,0.0155315848622995,HAVCR1/IL2RA/TGFBR2,3
GO:1903131,GO:1903131,mononuclear cell differentiation,3/20,433/18800,0.0103361924205749,0.0357883166297122,0.0160095744574291,CSF1/IL2RA/TGFBR2,3
GO:0046718,GO:0046718,viral entry into host cell,2/20,146/18800,0.0103839806552973,0.0357883166297122,0.0160095744574291,HAVCR1/NECTIN4,2
GO:2000377,GO:2000377,regulation of reactive oxygen species metabolic process,2/20,147/18800,0.0105205279717976,0.0357883166297122,0.0160095744574291,PON3/TGFBR2,2
GO:0001865,GO:0001865,NK T cell differentiation,1/20,10/18800,0.0105900370299883,0.0357883166297122,0.0160095744574291,TGFBR2,1
GO:0071838,GO:0071838,cell proliferation in bone marrow,1/20,10/18800,0.0105900370299883,0.0357883166297122,0.0160095744574291,FGFR2,1
GO:0099566,GO:0099566,regulation of postsynaptic cytosolic calcium ion concentration,1/20,10/18800,0.0105900370299883,0.0357883166297122,0.0160095744574291,CALB1,1
GO:0032103,GO:0032103,positive regulation of response to external stimulus,3/20,442/18800,0.0109289763221232,0.0361431023649682,0.0161682845947005,CSF1/PGF/SCG2,3
GO:0050673,GO:0050673,epithelial cell proliferation,3/20,443/18800,0.0109960467678471,0.0361431023649682,0.0161682845947005,FGFR2/PGF/SCG2,3
GO:0045785,GO:0045785,positive regulation of cell adhesion,3/20,446/18800,0.0111987094979551,0.0361431023649682,0.0161682845947005,CSF1/IL2RA/TGFBR2,3
GO:0003096,GO:0003096,renal sodium ion transport,1/20,11/18800,0.0116431609927022,0.0361431023649682,0.0161682845947005,PON3,1
GO:0006182,GO:0006182,cGMP biosynthetic process,1/20,11/18800,0.0116431609927022,0.0361431023649682,0.0161682845947005,NPPC,1
GO:0007614,GO:0007614,short-term memory,1/20,11/18800,0.0116431609927022,0.0361431023649682,0.0161682845947005,CALB1,1
GO:0021860,GO:0021860,pyramidal neuron development,1/20,11/18800,0.0116431609927022,0.0361431023649682,0.0161682845947005,FGFR2,1
GO:0031293,GO:0031293,membrane protein intracellular domain proteolysis,1/20,11/18800,0.0116431609927022,0.0361431023649682,0.0161682845947005,MMP7,1
GO:0034115,GO:0034115,negative regulation of heterotypic cell-cell adhesion,1/20,11/18800,0.0116431609927022,0.0361431023649682,0.0161682845947005,IL1RN,1
GO:0060174,GO:0060174,limb bud formation,1/20,11/18800,0.0116431609927022,0.0361431023649682,0.0161682845947005,FGFR2,1
GO:0022407,GO:0022407,regulation of cell-cell adhesion,3/20,456/18800,0.0118900282014984,0.036789600246844,0.0164574894791758,IL1RN/IL2RA/TGFBR2,3
GO:0001837,GO:0001837,epithelial to mesenchymal transition,2/20,162/18800,0.0126641096840328,0.0378079520770871,0.016913039809157,FGFR2/TGFBR2,2
GO:0032966,GO:0032966,negative regulation of collagen biosynthetic process,1/20,12/18800,0.0126952200048981,0.0378079520770871,0.016913039809157,NPPC,1
GO:0007568,GO:0007568,aging,2/20,163/18800,0.012813297699835,0.0379225860495116,0.0169643202629394,GFRA1/TGFBR2,2
GO:0033674,GO:0033674,positive regulation of kinase activity,3/20,476/18800,0.0133460205643079,0.039255424684523,0.0175605533740894,CSF1/FGFR2/TGFBR2,3
GO:0010713,GO:0010713,negative regulation of collagen metabolic process,1/20,13/18800,0.01374621508686,0.0394582619812578,0.0176512907741861,NPPC,1
GO:0021859,GO:0021859,pyramidal neuron differentiation,1/20,13/18800,0.01374621508686,0.0394582619812578,0.0176512907741861,FGFR2,1
GO:0036005,GO:0036005,response to macrophage colony-stimulating factor,1/20,13/18800,0.01374621508686,0.0394582619812578,0.0176512907741861,CSF1,1
GO:0060670,GO:0060670,branching involved in labyrinthine layer morphogenesis,1/20,13/18800,0.01374621508686,0.0394582619812578,0.0176512907741861,FGFR2,1
GO:0060572,GO:0060572,morphogenesis of an epithelial bud,1/20,15/18800,0.0158450175366064,0.0429599190939645,0.0192177248943012,FGFR2,1
GO:0071599,GO:0071599,otic vesicle development,1/20,15/18800,0.0158450175366064,0.0429599190939645,0.0192177248943012,FGFR2,1
GO:0045766,GO:0045766,positive regulation of angiogenesis,2/20,183/18800,0.0159578293381568,0.0429599190939645,0.0192177248943012,PGF/TGFBR2,2
GO:0048469,GO:0048469,cell maturation,2/20,183/18800,0.0159578293381568,0.0429599190939645,0.0192177248943012,AGRN/NPPC,2
GO:1904018,GO:1904018,positive regulation of vasculature development,2/20,183/18800,0.0159578293381568,0.0429599190939645,0.0192177248943012,PGF/TGFBR2,2
GO:0007565,GO:0007565,female pregnancy,2/20,185/18800,0.0162888514075309,0.0437275363137379,0.0195611114011861,PGF/TGFBR2,2
GO:0031099,GO:0031099,regeneration,2/20,188/18800,0.0167909324718558,0.0443494878075774,0.0198393356846179,PGF/TGFBR2,2
GO:0046068,GO:0046068,cGMP metabolic process,1/20,16/18800,0.0168928269403469,0.0443494878075774,0.0198393356846179,NPPC,1
GO:0051447,GO:0051447,negative regulation of meiotic cell cycle,1/20,16/18800,0.0168928269403469,0.0443494878075774,0.0198393356846179,NPPC,1
GO:1901741,GO:1901741,positive regulation of myoblast fusion,1/20,16/18800,0.0168928269403469,0.0443494878075774,0.0198393356846179,GDF15,1
GO:0048557,GO:0048557,embryonic digestive tract morphogenesis,1/20,17/18800,0.017939576485768,0.0463315703211914,0.0207260020766361,FGFR2,1
GO:0007213,GO:0007213,G protein-coupled acetylcholine receptor signaling pathway,1/20,19/18800,0.0200299000634387,0.0498394119071988,0.022295202764031,AGRN,1
GO:0010744,GO:0010744,positive regulation of macrophage derived foam cell differentiation,1/20,19/18800,0.0200299000634387,0.0498394119071988,0.022295202764031,CSF1,1
